While functionally this hypothesis seemed likely, clinically this did not prove to be true based on differences in the clinical presentation of patients with hypercalcemia due to cancer vs. those with hypercalcemia due to known PTH excess syndromes like primary hyperparathyroidism (5). This evidence concerns the gene PTH and Hypercalcemia.